as 07-26-2024 4:00pm EST
Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.
Founded: | 2013 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 111.3M | IPO Year: | N/A |
Target Price: | $5.25 | AVG Volume (30 days): | 1.9M |
Analyst Decision: | Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.43 | EPS Growth: | N/A |
52 Week Low/High: | $0.73 - $6.25 | Next Earning Date: | 08-05-2024 |
Revenue: | $48,698,000 | Revenue Growth: | 45.04% |
Revenue Growth (this year): | 24.02% | Revenue Growth (next year): | 29.50% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Breber Sandra | AUGX | CHIEF OPERATING OFFICER | May 15 '24 | Sell | $1.19 | 2,354 | $2,801.26 | 16,396 | SEC Form 4 |
Krakaris Emmanuel | AUGX | PRESIDENT, CEO, AND SECRETARY | May 15 '24 | Sell | $1.19 | 3,528 | $4,198.32 | 58,898 | SEC Form 4 |
Chatterjee Saurav | AUGX | CHIEF TECHNOLOGY OFFICER | May 15 '24 | Sell | $1.19 | 1,767 | $2,102.73 | 2,921 | SEC Form 4 |
Ginocchio Paul | AUGX | CHIEF FINANCIAL OFFICER | May 15 '24 | Sell | $1.19 | 2,354 | $2,801.26 | 131,896 | SEC Form 4 |
Hawkins Jonathan | AUGX | CHIEF REVENUE OFFICER | May 15 '24 | Sell | $1.19 | 1,767 | $2,102.73 | 2,921 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | May 15 '24 | Sell | $1.19 | 1,387 | $1,650.53 | 5,363 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 15 '24 | Sell | $3.80 | 500 | $1,900.00 | 3,000 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 12 '24 | Sell | $3.82 | 19,544 | $74,589.68 | 3,000 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 9 '24 | Sell | $4.14 | 31,542 | $130,520.80 | 3,000 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 9 '24 | Sell | $3.87 | 36,467 | $141,287.74 | 3,000 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 9 '24 | Sell | $3.93 | 24,778 | $97,476.65 | 3,000 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 5 '24 | Sell | $4.03 | 51,387 | $207,233.49 | 12,217 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 5 '24 | Sell | $3.97 | 28,563 | $113,380.83 | 12,217 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 5 '24 | Sell | $3.97 | 9,217 | $36,586.88 | 3,000 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 3 '24 | Sell | $4.11 | 45,906 | $188,600.21 | 95,665 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 3 '24 | Sell | $4.15 | 64,055 | $265,853.87 | 31,610 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 1 '24 | Sell | $3.89 | 51,346 | $199,684.59 | 187,666 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 1 '24 | Sell | $4.02 | 7,632 | $30,698.96 | 180,034 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Apr 1 '24 | Sell | $3.89 | 38,463 | $149,724.92 | 141,571 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Mar 28 '24 | Sell | $4.06 | 31,994 | $129,850.85 | 219,660 | SEC Form 4 |
Shakil Ian | AUGX | CHIEF STRATEGY OFFICER | Mar 28 '24 | Sell | $4.06 | 31,994 | $129,850.85 | 187,666 | SEC Form 4 |
AUGX Breaking Stock News: Dive into AUGX Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Healthcare Dive
5 days ago
Hospital Management
5 days ago
MT Newswires
7 days ago
MT Newswires
7 days ago
MT Newswires
7 days ago
MT Newswires
7 days ago
MT Newswires
7 days ago
The information presented on this page, "AUGX Augmedix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.